NDC 0078-0671 – Tykerb

Lapatinib Ditosylate 250 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC0078-0671

Product details

Brand name
Tykerb
Generic name
Lapatinib
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA022059
Marketed since
August 3, 2016
Listing expires
December 31, 2027
Pharmacologic class
Kinase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Tykerb →

Package NDC codes (1)

Package NDCDescriptionSince
0078-0671-19150 TABLET in 1 BOTTLE (0078-0671-19)Aug 3, 2016